Statin use and risk of nonmelanoma skin cancer: a nationwide study in Denmark

被引：0
|
作者：
S Arnspang
A Pottegård
S Friis
O Clemmensen
K E Andersen
J Hallas
D Gaist
机构：
[1] Clinical Pharmacology,Department of Clinical Chemistry & Pharmacology
[2] Institute of Public Health,Department of Public Health
[3] University of Southern Denmark,Department of Clinical Pathology
[4] Odense University Hospital,Department of Dermatology and Allergy Centre
[5] Danish Cancer Society Research Centre,Department of Neurology
[6] Faculty of Health,undefined
[7] Institute of Clinical Medicine,undefined
[8] Aarhus University,undefined
[9] University of Copenhagen,undefined
[10] Odense University Hospital,undefined
[11] Odense University Hospital,undefined
[12] Institute of Clinical Research,undefined
[13] Faculty of Health Sciences,undefined
[14] University of Southern Denmark,undefined
[15] Odense University Hospital,undefined
[16] Institute of Clinical Research,undefined
[17] Faculty of Health Sciences,undefined
[18] University of Southern Denmark,undefined
来源：
British Journal of Cancer | 2015年 / 112卷
关键词：
skin cancer; nonmelanoma; statins; risk; epidemiology; Denmark;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：153 / 156
页数：3
相关论文
共 50 条
  • [21] Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer
    Scott, Frank I.
    Mamtani, Ronac
    Brensinger, Colleen M.
    Haynes, Kevin
    Chiesa-Fuxench, Zelma C.
    Zhang, Jie
    Chen, Lang
    Xie, Fenglong
    Yun, Huifeng
    Osterman, Mark T.
    Beukelman, Timothy
    Margolis, David J.
    Curtis, Jeffrey R.
    Lewis, James D.
    JAMA DERMATOLOGY, 2016, 152 (02) : 164 - 172
  • [22] Cancer risk after nonmelanoma skin cancer
    Bonn, D
    LANCET, 1998, 352 (9131): : 885 - 885
  • [23] Statin use and risk for ovarian cancer: a Danish nationwide case-control study
    Baandrup, L.
    Dehlendorff, C.
    Friis, S.
    Olsen, J. H.
    Kjaer, S. K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (01) : 157 - 161
  • [24] Use of methotrexate and risk of skin cancer: a nationwide case–control study
    Sam Polesie
    Martin Gillstedt
    Sigrún Alba Jóhannesdóttir Schmidt
    Alexander Egeberg
    Anton Pottegård
    Kasper Kristensen
    British Journal of Cancer, 2023, 128 : 1311 - 1319
  • [25] Cohort Study of Nonmelanoma Skin Cancer and the Risk of Exfoliation Glaucoma
    Kang, Jae H.
    VoPham, Trang
    Laden, Francine
    Rosner, Bernard A.
    Wirostko, Barbara
    Ritch, Robert
    Wiggs, Janey L.
    Qureshi, Abrar
    Nan, Hongmei
    Pasquale, Louis R.
    JOURNAL OF GLAUCOMA, 2020, 29 (06) : 448 - 455
  • [26] Increased risk of nonmelanoma skin cancer in patients with alpha-1 antitrypsin deficiency: A nationwide cohort study
    Korsbaek, Nanna J.
    Landt, Eskild M.
    Marott, Sarah
    Nordestgaard, Borge G.
    Vinding, Gabrielle R.
    Jemec, Gregor B. E.
    Dahl, Morten
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [27] RISK REDUCTION FOR NONMELANOMA SKIN-CANCER WITH CHILDHOOD SUNSCREEN USE
    STERN, RS
    WEINSTEIN, MC
    BAKER, SG
    ARCHIVES OF DERMATOLOGY, 1986, 122 (05) : 537 - 545
  • [28] STATIN USE AND REDUCED STEMI RELATIVE TO NON-STEMI: A NATIONWIDE STUDY IN DENMARK
    Simony, S.
    Langsted, A.
    Mortensen, M.
    Nordestgaard, B.
    Afzal, S.
    ATHEROSCLEROSIS, 2023, 379
  • [29] Nationwide hospitalization costs of skin melanoma and nonmelanoma skin cancer in Germany.
    Stang, A.
    Stausberg, J.
    Boedeker, W.
    Kerek-Bodden, H.
    Joeckel, K.-H.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S99 - S99
  • [30] Statin use and breast cancer survival – a Swedish nationwide study
    Signe Borgquist
    Per Broberg
    Jasaman Tojjar
    Håkan Olsson
    BMC Cancer, 19
12345